Elevated serum autoantibodies against co-inhibitory PD-1 facilitate T cell proliferation and correlate with disease activity in new-onset systemic lupus erythematosus patients

Overview of attention for article published in Arthritis Research & Therapy, March 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (71st percentile)

Mentioned by

twitter: 5 tweeters
patent: 1 patent

facebook: 1 Facebook page

Citations

dimensions_citation: 22 Dimensions

Readers on

mendeley: 47 Mendeley

Summary Twitter Patents Facebook Dimensions citations

So far, Dimensions has found 22 publications that cite this research output.

22

The most recent citing publications are shown below. View all 22 publications that cite this research output on Dimensions.

Activation Markers on B and T Cells and Immune Checkpoints in Autoimmune Rheumatic Diseases

Article in International Journal of Molecular Sciences (August 2022)

Prediction of Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors With a Panel of Autoantibodies: Protocol of a Multicenter, Prospective, Observational Cohort Study

Article in Frontiers in Pharmacology (June 2022)

Anti-PD1/PDL1 IgG subclass distribution in ten cancer types and anti-PD1 IgG4 as biomarker for the long time survival in NSCLC with anti-PD1 therapy

Article in Cancer Immunology, Immunotherapy (November 2021)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.